ArticleBlood cancer journal2018

Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance.

Jingru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.